Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus

被引:15
|
作者
Lu, Xiuhua [1 ]
Liu, Feng [1 ]
Zeng, Hui [1 ]
Sheu, Tiffany [1 ]
Achenbach, Jenna E. [1 ]
Veguilla, Vic [1 ]
Gubareva, Larisa V. [1 ]
Garten, Rebecca [1 ]
Smith, Catherine [1 ]
Yang, Hua [1 ]
Stevens, James [1 ]
Xu, Xiyan [1 ]
Katz, Jacqueline M. [1 ]
Tumpey, Terrence M. [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA
关键词
Influenza virus; Anti-neuraminidase antibodies; Antigenic and genetic analyses; Passive immunization; BALB/c mice; Cross-protective immunity; 3-DIMENSIONAL STRUCTURE; VIRAL NEURAMINIDASE; ANTIBODY-RESPONSES; CRYSTAL-STRUCTURES; LETHAL INFLUENZA; VACCINE; H3N2; HEMAGGLUTININ; INFECTION; SEQUENCE;
D O I
10.1016/j.virol.2014.02.011
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To determine the genetic and antigenic relatedness as well as the cross-protective immunity of human HI NI and avian H5N1 influenza virus neuraminidase (NA), we immunized rabbits with either a baculovirus-expressed recombinant NA from A/Beijing/262/95 (BJ/262) H1N1 or A/Hong Kong/483/97 (HK/483) H5N1 virus. Cross-reactive antibody responses were evaluated by multiple serological assays and cross-protection against H5N1 virus challenge was evaluated in mice. In a neuraminidase inhibition (NI) test, the antisera exhibited substantial inhibition of NA activity of the homologous virus, but failed to inhibit the NA activity of heterologous virus. However, these antisera exhibited low levels of cross-reactivity measured by plaque size reduction, replication inhibition, single radial hemolysis, and ELISA assays. Passive immunization with HK/483 NA-specific antisera significantly reduced virus replication and disease, and afforded almost complete protection against lethal homologous virus challenge in mice. However, passive immunization with BJ/262 (H1N1) NA-specific antisera was ineffective at providing cross-protection against lethal H5N1 virus challenge and only slightly reduced weight loss. Substantial amino acid variation among the NA antigenic sites was observed between BJ/262 and HK/483 virus, which was consistent with the lack of cross-reactive NI activity by the antibody and limited cross-protective immunity in mice. These results show a strong correlation between the lack of cross-protective immunity and low structural similarities of NA from a human seasonal HI NI virus and an avian H5N1 influenza virus. Published by Elsevier Inc
引用
收藏
页码:169 / 175
页数:7
相关论文
共 50 条
  • [21] Dogs are highly susceptible to H5N1 avian influenza virus
    Chen, Ying
    Zhong, Gongxun
    Wang, Guojun
    Deng, Guohua
    Li, Yanbing
    Shi, Jianzhong
    Zhang, Zhuo
    Guan, Yuntao
    Jiang, Yongping
    Bu, Zhigao
    Kawaoka, Yoshihiro
    Chen, Hualan
    VIROLOGY, 2010, 405 (01) : 15 - 19
  • [22] Receptor recognition mechanism of human influenza A H1N1 (1918), avian influenza A H5N1 (2004), and pandemic H1N1 (2009) neuraminidase
    Jongkon, Nipa
    Sangma, Chak
    JOURNAL OF MOLECULAR MODELING, 2012, 18 (01) : 285 - 293
  • [23] Evolution of highly pathogenic avian influenza (H5N1) virus populations in Vietnam between 2007 and 2010
    Tung Nguyen
    Rivailler, Pierre
    Davis, C. Todd
    Do Thi Hoa
    Balish, Amanda
    Nguyen Hoang Dang
    Jones, Joyce
    Dam Thi Vui
    Simpson, Natosha
    Ngo Thu Huong
    Shu, Bo
    Loughlin, Rosette
    Ferdinand, Karen
    Lindstrom, Stephen E.
    York, Ian A.
    Klimov, Alexander
    Donis, Ruben O.
    VIROLOGY, 2012, 432 (02) : 405 - 416
  • [24] Recombinant Parainfluenza Virus 5 Expressing Hemagglutinin of Influenza A Virus H5N1 Protected Mice against Lethal Highly Pathogenic Avian Influenza Virus H5N1 Challenge
    Li, Zhuo
    Mooney, Alaina J.
    Gabbard, Jon D.
    Gao, Xiudan
    Xu, Pei
    Place, Ryan J.
    Hogan, Robert J.
    Tompkins, S. Mark
    He, Biao
    JOURNAL OF VIROLOGY, 2013, 87 (01) : 354 - 362
  • [25] Human Infection with Highly Pathogenic Avian Influenza A (H5N1) Virus: Review of Clinical Issues
    Uyeki, Timothy M.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (02) : 279 - 290
  • [26] Inferring the antigenic epitopes for highly pathogenic avian influenza H5N1 viruses
    Peng, Yousong
    Zou, Yuanqiang
    Li, Honglei
    Li, Kenli
    Jiang, Taijiao
    VACCINE, 2014, 32 (06) : 671 - 676
  • [27] In vitro and in vivo characterization of a novel H1N1/2009 influenza virus reassortant with an NS gene from a highly pathogenic H5N1 virus, isolated from a human
    Liu, Shengbing
    Zhang, Liangyan
    Yao, Zhidong
    Xing, Li
    Liu, Kun
    ARCHIVES OF VIROLOGY, 2017, 162 (09) : 2633 - 2642
  • [28] Viral Load of the Highly Pathogenic Avian Influenza H5N1 Virus in Infected Human Tissues
    Sirinonthanawech, Naraporn
    Uiprasertkul, Mongkol
    Suptawiwat, Ornpreya
    Auewarakul, Prasert
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (08) : 1418 - 1423
  • [29] Characterization of H5N1 influenza A virus that caused the first highly pathogenic avian influenza outbreak in Saudi Arabia
    Al-Qahtani, Ahmed A.
    Mubin, Muhammad
    Almajhdi, Fahad N.
    Alarifi, Saud
    Dela Cruz, Damian M.
    ul Rehman, Muhammad Shah Nawaz
    Ismail, Mahmoud Moussa
    Ahmed, Nisar
    Al-Blowi, Mohamed H.
    Khalak, Hanif
    Al-Ahdal, Mohammed N.
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2015, 9 (11): : 1210 - 1219
  • [30] Development of a sensitive novel diagnostic kit for the highly pathogenic avian influenza A (H5N1) virus
    Tsunetsugu-Yokota, Yasuko
    Nishimura, Kengo
    Misawa, Shuhei
    Kobayashi-Ishihara, Mie
    Takahashi, Hitoshi
    Takayama, Ikuyo
    Ohnishi, Kazuo
    Itamura, Shigeyuki
    Nguyen, Hang L. K.
    Le, Mai T. Q.
    Dang, Giang T.
    Nguyen, Long T.
    Tashiro, Masato
    Kageyama, Tsutomu
    BMC INFECTIOUS DISEASES, 2014, 14